


To achieve capital growth in the long term by investing mainly in European companies excluding the U.K. The Halifax European Life and Pension funds invest directly into the Halifax European OEIC.
| Name | % Net Assets |
|---|---|
| NESTLE SA COMSTK | 3.4% |
| Total | 3.1% |
| Telefonica | 2.5% |
| Novartis (regd) | 2.3% |
| Roche Hldgs (genus) | 2.2% |
| Banco Santander S.a. | 2.0% |
| E.ON AG | 1.7% |
| Gdf Suez | 1.6% |
| Sanofi-aventis | 1.6% |
| Siemens Ag | 1.5% |
| Key | % Net Assets |
|---|---|
| 3.4% | |
| 3.1% | |
| 2.5% | |
| 2.3% | |
| 88.7% |
| Date | 18-Oct-2024 |
|---|---|
| NAV | 128.00p |
| Currency | GBP |
| Change | -0.40p |
| % | -0.31% |
| YTD change | 128.00p |
| YTD % | n/a |
| Fund Inception | 19/06/1987 |
|---|---|
| Fund Manager | Richard Wiseman |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.06 |
You are here: research